茯砖茶对肠道菌群及代谢综合征的调节作用研究进展
Research Progress on the Regulatory Effects of Fuzhuan Brick Tea on Gut Microbiota and Metabolic Syndrome
DOI: 10.12677/acm.2024.14123180, PDF,   
作者: 李 雪, 邢 琳:西安医学院研究生处,陕西 西安;王军奎*:陕西省人民医院心血管内科,陕西 西安
关键词: 茯砖茶肠道菌群代谢综合征Fuzhuan Brick Tea Gut Microbiota Metabolic Syndrome
摘要: 茯砖茶是一种传统的后发酵茶,其中所含冠突散囊菌(Eurotium cristatum),也被称为“金花”,是其区别于其他茶叶的关键。研究表明长期饮用茯砖茶具有抗肥胖、降糖、降脂、调节肠道菌群、抗炎等多重药理作用。代谢综合征(Metabolic syndrome, MS)是一组代谢紊乱性疾病的总称,其特征是向心性肥胖、血脂异常、血压升高、高血糖状态,已成为全球性的公共卫生问题。目前没有单一药物能够全面治疗代谢综合征的所有症状,人们越来越关注天然食品在预防和治疗代谢综合征中的作用。茯砖茶中的活性成分,如茶多酚、茶多糖等,可以通过调节肠道菌群的结构和功能,进而影响宿主的代谢过程。本文综述了茯砖茶通过调节肠道菌群改善MS的研究进展,以期为MS的防治提供新思路。
Abstract: Fuzhuan brick tea is a traditional post-fermented tea, in which the presence of Eurotium cristatum, also known as “golden flower”, is a key distinguishing feature from other tea varieties. Studies have shown that long-term consumption of Fuzhuan brick tea has multiple pharmacological effects, including anti-obesity, anti-diabetes, anti-lipid, regulation of gut microbiota, and anti-inflammation. Metabolic syndrome (MS) is a group of metabolic disorders characterized by central obesity, dyslipidemia, hypertension, and hyperglycemia, and has become a global public health problem. Currently, there is no single drug that can comprehensively treat all symptoms of MS, and people are increasingly paying attention to the role of natural foods in the prevention and treatment of MS. Active components in Fuzhuan brick tea, such as tea polyphenols and polysaccharides, can regulate the structure and function of gut microbiota, thereby influencing the host’s metabolic process. This review summarizes the progress of research on how Fuzhuan brick tea regulates gut microbiota to improve MS, with the aim of providing new insights into the prevention and treatment of MS.
文章引用:李雪, 王军奎, 邢琳. 茯砖茶对肠道菌群及代谢综合征的调节作用研究进展[J]. 临床医学进展, 2024, 14(12): 1016-1023. https://doi.org/10.12677/acm.2024.14123180

参考文献

[1] Wu, Q., Dong, Q., Sun, W., Huang, Y., Wang, Q. and Zhou, W. (2014) Discrimination of Chinese Teas with Different Fermentation Degrees by Stepwise Linear Discriminant Analysis (S-LDA) of the Chemical Compounds. Journal of Agricultural and Food Chemistry, 62, 9336-9344. [Google Scholar] [CrossRef] [PubMed]
[2] Li, J., Xu, R., Zong, L., Brake, J., Cheng, L., Wu, J., et al. (2021) Dynamic Evolution and Correlation between Metabolites and Microorganisms during Manufacturing Process and Storage of Fu Brick Tea. Metabolites, 11, Article 703. [Google Scholar] [CrossRef] [PubMed]
[3] Fan, Y. and Pedersen, O. (2020) Gut Microbiota in Human Metabolic Health and Disease. Nature Reviews Microbiology, 19, 55-71. [Google Scholar] [CrossRef] [PubMed]
[4] Jasirwan, C.O.M., Muradi, A., Hasan, I., Simadibrata, M. and Rinaldi, I. (2021) Correlation of Gut Firmicutes/Bacteroidetes Ratio with Fibrosis and Steatosis Stratified by Body Mass Index in Patients with Non-Alcoholic Fatty Liver Disease. Bioscience of Microbiota, Food and Health, 40, 50-58. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, G., Xie, M., Wan, P., Chen, D., Dai, Z., Ye, H., et al. (2018) Fuzhuan Brick Tea Polysaccharides Attenuate Metabolic Syndrome in High-Fat Diet Induced Mice in Association with Modulation in the Gut Microbiota. Journal of Agricultural and Food Chemistry, 66, 2783-2795. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, M., Chen, G., Chen, D., Ye, H., Sun, Y., Zeng, X., et al. (2019) Purified Fraction of Polysaccharides from Fuzhuan Brick Tea Modulates the Composition and Metabolism of Gut Microbiota in Anaerobic Fermentation in Vitro. International Journal of Biological Macromolecules, 140, 858-870. [Google Scholar] [CrossRef] [PubMed]
[7] Yang, W., Ren, D., Zhao, Y., Liu, L. and Yang, X. (2021) Fuzhuan Brick Tea Polysaccharide Improved Ulcerative Colitis in Association with Gut Microbiota-Derived Tryptophan Metabolism. Journal of Agricultural and Food Chemistry, 69, 8448-8459. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, B., Ren, D., Zhao, A., Shao, H., Li, T., Niu, P., et al. (2022) Eurotium cristatum Exhibited Anti-Colitis Effects via Modulating Gut Microbiota-Dependent Tryptophan Metabolism. Journal of Agricultural and Food Chemistry, 70, 16164-16175. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, G., Xie, M., Wan, P., Chen, D., Ye, H., Chen, L., et al. (2018) Digestion under Saliva, Simulated Gastric and Small Intestinal Conditions and Fermentation in Vitro by Human Intestinal Microbiota of Polysaccharides from Fuzhuan Brick Tea. Food Chemistry, 244, 331-339. [Google Scholar] [CrossRef] [PubMed]
[10] Foster, M.T., Gentile, C.L., Cox-York, K., Wei, Y., Wang, D., Estrada, A.L., et al. (2016) Fuzhuan Tea Consumption Imparts Hepatoprotective Effects and Alters Intestinal Microbiota in High Saturated Fat Diet-Fed Rats. Molecular Nutrition & Food Research, 60, 1213-1220. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, C., Zhou, X., Wen, Z., Liu, L., Yang, Z., Yang, L., et al. (2020) Compound Fu Brick Tea Modifies the Intestinal Microbiome Composition in High-Fat Diet-Induced Obesity Mice. Food Science & Nutrition, 8, 5508-5520. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, D., Huang, J., Luo, Y., Wen, B., Wu, W., Zeng, H., et al. (2019) Fuzhuan Brick Tea Attenuates High-Fat Diet-Induced Obesity and Associated Metabolic Disorders by Shaping Gut Microbiota. Journal of Agricultural and Food Chemistry, 67, 13589-13604. [Google Scholar] [CrossRef] [PubMed]
[13] Shivaji, S. (2019) Connect between Gut Microbiome and Diseases of the Human Eye. Journal of Biosciences, 44, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
[14] Cani, P.D. (2019) Microbiota and Metabolites in Metabolic Diseases. Nature Reviews Endocrinology, 15, 69-70. [Google Scholar] [CrossRef] [PubMed]
[15] Amsterdam, J.D., Li, Q.S., Xie, S.X. and Mao, J.J. (2020) Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression. The Journal of Alternative and Complementary Medicine, 26, 815-821. [Google Scholar] [CrossRef] [PubMed]
[16] Ding, R., Goh, W., Wu, R., Yue, X., Luo, X., Khine, W.W.T., et al. (2019) Revisit Gut Microbiota and Its Impact on Human Health and Disease. Journal of Food and Drug Analysis, 27, 623-631. [Google Scholar] [CrossRef] [PubMed]
[17] Régnier, M., Van Hul, M., Knauf, C. and Cani, P.D. (2021) Gut Microbiome, Endocrine Control of Gut Barrier Function and Metabolic Diseases. Journal of Endocrinology, 248, R67-R82. [Google Scholar] [CrossRef] [PubMed]
[18] de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C. and Raybould, H.E. (2010) Propensity to High-Fat Diet-Induced Obesity in Rats Is Associated with Changes in the Gut Microbiota and Gut Inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology, 299, G440-G448. [Google Scholar] [CrossRef] [PubMed]
[19] Chen, D., Yang, Z., Chen, X., Huang, Y., Yin, B., Guo, F., et al. (2015) Effect of Lactobacillus Rhamnosus Hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. Journal of Microbiology and Biotechnology, 25, 687-695. [Google Scholar] [CrossRef] [PubMed]
[20] Wieser, V., Moschen, A.R. and Tilg, H. (2013) Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective. Archivum Immunologiae et Therapiae Experimentalis, 61, 119-125. [Google Scholar] [CrossRef] [PubMed]
[21] Brooks, L., Viardot, A., Tsakmaki, A., Stolarczyk, E., Howard, J.K., Cani, P.D., et al. (2017) Fermentable Carbohydrate Stimulates Ffar2-Dependent Colonic PYY Cell Expansion to Increase Satiety. Molecular Metabolism, 6, 48-60. [Google Scholar] [CrossRef] [PubMed]
[22] Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. and Kimura, I. (2015) Dietary Gut Microbial Metabolites, Short-Chain Fatty Acids, and Host Metabolic Regulation. Nutrients, 7, 2839-2849. [Google Scholar] [CrossRef] [PubMed]
[23] Guo, P., Feng, J.P., Feng, C., et al. (2019) Research Advances in Gut Flora and Related Diseases. Chinese Journal of Internal Medicine, 58, 476-480.
[24] 晏群, 冯波. 肠道菌群、肠促胰素与糖代谢异常[J]. 上海医学, 2021, 44(10): 722-725.
[25] Song, X., Sun, X., Oh, S.F., Wu, M., Zhang, Y., Zheng, W., et al. (2019) Microbial Bile Acid Metabolites Modulate Gut Rorγ+ Regulatory T Cell Homeostasis. Nature, 577, 410-415. [Google Scholar] [CrossRef] [PubMed]
[26] Agus, A., Clément, K. and Sokol, H. (2020) Gut Microbiota-Derived Metabolites as Central Regulators in Metabolic Disorders. Gut, 70, 1174-1182. [Google Scholar] [CrossRef] [PubMed]
[27] Wu, J., Wang, K., Wang, X., Pang, Y. and Jiang, C. (2020) The Role of the Gut Microbiome and Its Metabolites in Metabolic Diseases. Protein & Cell, 12, 360-373. [Google Scholar] [CrossRef] [PubMed]
[28] González Hernández, M.A., Canfora, E.E., Jocken, J.W.E. and Blaak, E.E. (2019) The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients, 11, Article 1943. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, D., Liu, C., Tian, M., Tan, C., Shu, G., Jiang, Q., et al. (2019) Propionate Promotes Intestinal Lipolysis and Metabolic Benefits via AMPK/LSD1 Pathway in Mice. Journal of Endocrinology, 243, 187-197. [Google Scholar] [CrossRef] [PubMed]
[30] Wieser, V., Moschen, A.R. and Tilg, H. (2013) Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective. Archivum Immunologiae et Therapiae Experimentalis, 61, 119-125. [Google Scholar] [CrossRef] [PubMed]
[31] Brooks, L., Viardot, A., Tsakmaki, A., Stolarczyk, E., Howard, J.K., Cani, P.D., et al. (2017) Fermentable Carbohydrate Stimulates Ffar2-Dependent Colonic PYY Cell Expansion to Increase Satiety. Molecular Metabolism, 6, 48-60. [Google Scholar] [CrossRef] [PubMed]
[32] Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. and Kimura, I. (2015) Dietary Gut Microbial Metabolites, Short-Chain Fatty Acids, and Host Metabolic Regulation. Nutrients, 7, 2839-2849. [Google Scholar] [CrossRef] [PubMed]
[33] Pasanisi, F., Contaldo, F., de Simone, G., et al. (2001) Benefits of Sustained Moderate Weight Loss in Obesity. Nutrition, Metabolism and Cardiovascular Diseases, 11, 401-406.
[34] Li, Q., Liu, Z., Huang, J., Luo, G., Liang, Q., Wang, D., et al. (2012) Anti-Obesity and Hypolipidemic Effects of Fuzhuan Brick Tea Water Extract in High-Fat Diet-Induced Obese Rats. Journal of the Science of Food and Agriculture, 93, 1310-1316. [Google Scholar] [CrossRef] [PubMed]
[35] Zeng, Z., Xie, Z., Chen, G., Sun, Y., Zeng, X. and Liu, Z. (2022) Anti-Inflammatory and Gut Microbiota Modulatory Effects of Polysaccharides from Fuzhuan Brick Tea on Colitis in Mice Induced by Dextran Sulfate Sodium. Food & Function, 13, 649-663. [Google Scholar] [CrossRef] [PubMed]
[36] Zhou, M., Tian, X., Wu, Z., Li, K. and Li, Z. (2021) Fuzhuan Brick Tea Supplemented with Areca Nuts: Effects on Serum and Gut Microbiota in Mice. Journal of Food Biochemistry, 45, e13737. [Google Scholar] [CrossRef] [PubMed]
[37] Tang, Y., Chen, B., Huang, X., He, X., Yi, J., Zhao, H., et al. (2022) Fu Brick Tea Alleviates High Fat Induced Non-Alcoholic Fatty Liver Disease by Remodeling the Gut Microbiota and Liver Metabolism. Frontiers in Nutrition, 9, Article 1062323. [Google Scholar] [CrossRef] [PubMed]
[38] Ye, Y., Warusawitharana, H., Zhao, H., Liu, Z., Li, B., Wu, Y., et al. (2022) Tea Polyphenols Attenuates Inflammation via Reducing Lipopolysaccharides Level and Inhibiting TLR4/NF-κB Pathway in Obese Mice. Plant Foods for Human Nutrition, 77, 105-111. [Google Scholar] [CrossRef] [PubMed]
[39] Zhu, M., Ouyang, J., Zhou, F., Zhao, C., Zhu, W., Liu, C., et al. (2023) Polysaccharides from Fu Brick Tea Ameliorate Obesity by Modulating Gut Microbiota and Gut Microbiota-Related Short Chain Fatty Acid and Amino Acid Metabolism. The Journal of Nutritional Biochemistry, 118, Article 109356. [Google Scholar] [CrossRef] [PubMed]
[40] Wang, Y., Zhao, A., Du, H., Liu, Y., Qi, B. and Yang, X. (2021) Theabrownin from Fu Brick Tea Exhibits the Thermogenic Function of Adipocytes in High-Fat-Diet-Induced Obesity. Journal of Agricultural and Food Chemistry, 69, 11900-11911. [Google Scholar] [CrossRef] [PubMed]
[41] Liu, T., Liu, X., Huang, G., Liu, L., Chen, Q. and Wang, Q. (2022) Theophylline Extracted from Fu Brick Tea Affects the Metabolism of Preadipocytes and Body Fat in Mice as a Pancreatic Lipase Inhibitor. International Journal of Molecular Sciences, 23, Article 2525. [Google Scholar] [CrossRef] [PubMed]
[42] Yoo, A., Jung Kim, M., Ahn, J., Hwa Jung, C., Deok Seo, H., Yung Ly, S., et al. (2022) Fuzhuan Brick Tea Extract Prevents Diet-Induced Obesity via Stimulation of Fat Browning in Mice. Food Chemistry, 377, Article 132006. [Google Scholar] [CrossRef] [PubMed]
[43] (1998) Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. The Lancet, 352, 854-865.
[44] Fang, Z.Y., Prins, J.B. and Marwick, T.H. (2004) Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications. Endocrine Reviews, 25, 543-567. [Google Scholar] [CrossRef] [PubMed]
[45] Zhu, J., Yu, C., Zhou, H., Wei, X. and Wang, Y. (2021) Comparative Evaluation for Phytochemical Composition and Regulation of Blood Glucose, Hepatic Oxidative Stress and Insulin Resistance in Mice and HEPG2 Models of Four Typical Chinese Dark Teas. Journal of the Science of Food and Agriculture, 101, 6563-6577. [Google Scholar] [CrossRef] [PubMed]
[46] Du, H., Wang, Q. and Yang, X. (2019) Fu Brick Tea Alleviates Chronic Kidney Disease of Rats with High Fat Diet Consumption through Attenuating Insulin Resistance in Skeletal Muscle. Journal of Agricultural and Food Chemistry, 67, 2839-2847. [Google Scholar] [CrossRef] [PubMed]
[47] Huang, H., Chen, J., Hu, X., Chen, Y., Xie, J., Ao, T., et al. (2022) Elucidation of the Interaction Effect between Dietary Fiber and Bound Polyphenol Components on the Anti-Hyperglycemic Activity of Tea Residue Dietary Fiber. Food & Function, 13, 2710-2728. [Google Scholar] [CrossRef] [PubMed]
[48] Liu, Q., Chen, L., Hu, L., Guo, Y. and Shen, X. (2010) Small Molecules from Natural Sources, Targeting Signaling Pathways in Diabetes. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1799, 854-865. [Google Scholar] [CrossRef] [PubMed]
[49] Lu, Y., He, Y., Zhu, S., Zhong, X., Chen, D. and Liu, Z. (2019) New Acylglycosides Flavones from Fuzhuan Brick Tea and Simulation Analysis of Their Bioactive Effects. International Journal of Molecular Sciences, 20, Article 494. [Google Scholar] [CrossRef] [PubMed]
[50] Hillis, L.D., Smith, P.K., Anderson, J.L., Bittl, J.A., Bridges, C.R., Byrne, J.G., et al. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary. Circulation, 124, 2610-2642. [Google Scholar] [CrossRef] [PubMed]
[51] Chen, G., Xie, M., Dai, Z., Wan, P., Ye, H., Zeng, X., et al. (2018) Kudingcha and Fuzhuan Brick Tea Prevent Obesity and Modulate Gut Microbiota in High-Fat Diet Fed Mice. Molecular Nutrition & Food Research, 62, e1700145. [Google Scholar] [CrossRef] [PubMed]
[52] Liu, Z., Lin, Y., Zhang, S., Wang, D., Liang, Q. and Luo, G. (2015) Comparative Proteomic Analysis Using 2DE-LC-MS/MS Reveals the Mechanism of Fuzhuan Brick Tea Extract against Hepatic Fat Accumulation in Rats with Nonalcoholic Fatty Liver Disease. Electrophoresis, 36, 2002-2016. [Google Scholar] [CrossRef] [PubMed]
[53] Cave, M.C., Clair, H.B., Hardesty, J.E., Falkner, K.C., Feng, W., Clark, B.J., et al. (2016) Nuclear Receptors and Nonalcoholic Fatty Liver Disease. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1859, 1083-1099. [Google Scholar] [CrossRef] [PubMed]
[54] Satoh, H., Ide, N., Kagawa, Y. and Maeda, T. (2013) Hepatic Steatosis with Relation to Increased Expression of Peroxisome Proliferator-Activated Receptor-γ in Insulin Resistant Mice. Biological and Pharmaceutical Bulletin, 36, 616-623. [Google Scholar] [CrossRef] [PubMed]